Cover Image

Inactivated enterovirus A71 vaccines and moving forward

Saved in:

Bibliographic Details
Main Author:	Hiroyuki Shimizu (Author)
Format:	Book
Published:	Elsevier, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
by: Shi-Hsia Hwa, et al.
Published: (2013)

Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints
by: Wenbo Zhu, et al.
Published: (2017)

Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China
by: Lixia Ye, et al.
Published: (2021)

Challenges to licensure of enterovirus 71 vaccines.
by: Min-Shi Lee, et al.
Published: (2012)

Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation
by: Yuemei Hu, et al.
Published: (2018)

Enterovirus 71 in Taiwan
by: Luan-Yin Chang
Published: (2008)

Enterovirus 71 Meningoencephalitis
by: J Gordon Millichap
Published: (1999)

Enterovirus 71 Meningoencephalitis
by: J Gordon Millichap
Published: (1999)

Effectiveness of Enterovirus 71 inactivated vaccines against hand, foot, and mouth disease: A test-negative case-control study
by: Yutong Zhang, et al.
Published: (2024)

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial
by: Yajun Shu, et al.
Published: (2024)

The need for development of other enterovirus vaccines in addition to EV-A71 vaccine
by: Daoyan Xu, et al.
Published: (2024)

Enterovirus 71 CNS Infection and ADHD
by: J Gordon Millichap
Published: (2008)

Neurologic Complications of Enterovirus 71 Infection
by: J Gordon Millichap
Published: (1999)

Enterovirus 71 infection and neurological complications
by: Kyung Yeon Lee
Published: (2016)

Epidemiology of Enterovirus 71 Infections in Taiwan
by: Min-Yuan Chia, et al.
Published: (2014)

Cost-effectiveness of a national enterovirus 71 vaccination program in China.
by: Wenjun Wang, et al.
Published: (2017)

Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China
by: Xiaoli Wang, et al.
Published: (2019)

Children with severe enterovirus A71 infection
by: Wenjuan Wu, et al.
Published: (2023)

Safety of an inactivated enterovirus 71 vaccine administered concurrently with other vaccines among infants aged 6-11 months: An observational study using active surveillance
by: Linlin Wu, et al.
Published: (2024)

Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial
by: Yan Li, et al.
Published: (2021)

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris
by: Zhijian Yang, et al.
Published: (2020)

Enterovirus 71 infection: An experience in Korea, 2009
by: Kyung Hyo Kim
Published: (2010)

Enterovirus 71, One Virus and Many Stories
by: Shih-Min Wang, et al.
Published: (2008)

Milrinone in Enterovirus 71 Brain Stem Encephalitis
by: SHIH-MIN eWANG, et al.
Published: (2016)

Curcumin inhibits the replication of enterovirus 71 in vitro
by: Ying Qin, et al.
Published: (2014)

Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development.
by: Min-Yuan Chia, et al.
Published: (2014)

Enterovirus A71 antivirals: Past, present, and future
by: Jun Wang, et al.
Published: (2022)

CLINICAL AND LABORATORY CHARACTERISTICS OF THE INFECTION CAUSED BY ENTEROVIRUS-71
by: E. N. Simovanyan, et al.
Published: (2015)

Enterovirus 71 Brainstem Encephalitis and Cognitive and Motor Deficits
by: J Gordon Millichap
Published: (2006)

Short-term dynamic changes in neutralizing antibodies against enterovirus 71 after vaccination
by: Shenyu Wang, et al.
Published: (2020)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial
by: Xiaoyu Liu, et al.
Published: (2021)

Clinical manifestations of CNS infections caused by enterovirus type 71
by: Cheol Soon Choi, et al.
Published: (2011)

Seroprevalence of human enterovirus A71 in Guangzhou, China, 2019-2021
by: Huimin Lian, et al.
Published: (2023)

Vemurafenib Inhibits Enterovirus A71 Genome Replication and Virus Assembly
by: Bodan Hu, et al.
Published: (2022)

Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
by: Yueh-Liang Tsou, et al.
Published: (2015)

Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.
by: Mei-Liang Huang, et al.
Published: (2013)

Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys
by: Ting Yang, et al.
Published: (2020)

The secular trend of enterovirus A71 after the implementation of preventive measures in Taiwan
by: Ya-Li Hu, et al.
Published: (2022)

Massive pulmonary hemorrhage in enterovirus 71-infected hand, foot, and mouth disease
by: Dong Seong Lee, et al.
Published: (2015)

CNS Pathology in Children with Enterovirus-71 Infection during Epidemic and Interepidemic Periods
by: E. N. Simovanyan, et al.
Published: (2015)